OP0002 Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomised, Placebo-Controlled, Dose-Ranging Study
van der Heijde, D., Deodhar, A., Wei, J.C., Drescher, E., Fleishaker, D., Hendrikx, T., Li, D., Menon, S., Kanik, K.Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.1847
Date:
June, 2016
File:
PDF, 250 KB
english, 2016